Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C

NCT05531097 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Elevated LDL-C

Interventions

DRUG: HSK31679
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.